News Sentiment

NMTC sentiment intelligence

Neuroone Medical Technologies Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 64 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 2.88 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 64

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-4.0% over one week, -11.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial

Market Reaction

Price moving ahead of tone

57/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction -4.0% Price reacting lower
Trend fit Trend inactive -11.1% over four weeks
Fair value -47.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 44
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 64
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 20
Stock Titan 8
NewMediaWire 5
TradingKey 5
dars.gov.et 2
StockStory 2
GuruFocus.com 2
Investing.com Nigeria 1

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 25
Analyst action 2
Macro sensitivity 2
Deals and strategy 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 64
Stock Titan Direct company coverage

Brian and Barbara Pratt disclose 12.5% NeuroOne stake (NASDAQ: NMTC)

Brian and Barbara Pratt have disclosed a beneficial ownership of 1,085,934 common shares in NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), representing 12.5% of the company's outstanding shares. This stake is held in a joint account, granting them shared voting and dis

Tone
Neutral 50/100
Event
Deals and strategy
Published
14 Jul 2026 20:11
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June By Investing.com

This article announces the filing of Form 144 by NEUROONE MEDICAL TECHNOLOGIES Corp for June 30. It is a very brief news item, primarily serving as a notification rather than providing detailed analysis. The article includes standard financial market data and popular news links c

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 18:39
Source
Investing.com Nigeria
GuruFocus Direct company coverage

Insider Sell: Mark Christianson Sells 10,000 Shares of NeuroOne Medical Technologies Corp (NMTC)

Mark Christianson, Market Development Director at NeuroOne Medical Technologies Corp (NMTC), sold 10,000 shares of the company on June 30, 2026, reducing his holding to 20,692 shares. Over the past year, Christianson has sold a total of 70,000 shares with no purchases. NMTC share

Tone
Negative 29/100
Event
Market update
Published
03 Jul 2026 07:09
Source
GuruFocus
Stock Titan Direct company coverage

NMTC (NMTC) director sells 10,000 shares, retains 20,692 after trade

Mark Christianson, the Market Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 10,000 shares of common stock at an average price of $3.1773 per share. Following this open-market transaction, he still directly holds 20,692 shares, indicating a continued, sub

Tone
Negative 38/100
Event
Market update
Published
02 Jul 2026 21:09
Source
Stock Titan
Stock Titan Direct company coverage

[144] NEUROONE MEDICAL TECHNOLOGIES Corp SEC Filing

Mark A. Christianson has filed a Form 144 to sell up to 10,000 shares of NeuroOne Medical Technologies Corp. common stock, valued at an aggregate of $33,400. The filing also documents previous sales in March 2026, totaling 30,692 shares acquired via award on April 20, 2026. This

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 13:09
Source
Stock Titan
Investing.com Canada Direct company coverage

Form DEF 14A Neuroone Medical Technologies Corp For: 26 June By Investing.com

This article reports on the filing of Form DEF 14A by Neuroone Medical Technologies Corp for June 26. It mentions the company's stock symbol NMTC, which showed a 4.38% increase. The piece provides a brief financial update on the company.

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 22:09
Source
Investing.com Canada
Market source Direct company coverage

NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NeuroOne Medical Technologies Corporation announced an equity award grant under its 2021 Inducement Plan to a new employee, effective June 24, 2026. This grant, in compliance with Nasdaq Listing Rule 5635(c)(4), is an option to purchase 10,000 shares of common stock with an exerc

Tone
Positive 65/100
Event
Market update
Published
26 Jun 2026 02:40
Source
Market source
Intellectia AI Direct company coverage

NMTC Should I Buy

NeuroOne Medical Technologies Corp (NMTC) is not recommended as a strong buy for long-term investors due to bearish technical indicators, lack of recent positive news, and absence of strong proprietary trading signals. While a recent analyst rating from Ladenburg increased the pr

Tone
Neutral 50/100
Event
Analyst action
Published
22 Jun 2026 11:40
Source
Intellectia AI
TradingKey Direct company coverage

NeuroOne Medical Technologies Corp (NMTC) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of NeuroOne Medical Technologies Corp (NMTC), noting its current valuation score of 9.50 and a P/E ratio of -1.11. The company ranks 12th out of 203 in the Healthcare Equipment & Supplies industry. Key valuation metrics like P/B, P/S, an

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 22:40
Source
TradingKey
TradingKey Direct company coverage

NeuroOne Medical Technologies Corp (NMTC) Institutional Confidence

The article provides an analysis of NeuroOne Medical Technologies Corp (NMTC) institutional confidence score, which currently stands at 3.00, ranking it 132 out of 203 in the Healthcare Equipment & Supplies industry. It highlights that the institutional shareholding proportion is

Tone
Negative 40/100
Event
Market update
Published
18 Jun 2026 22:10
Source
TradingKey
TradingKey Direct company coverage

NeuroOne Medical Technologies Corp (NMTC) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for NeuroOne Medical Technologies Corp (NMTC), indicating a current earnings forecast score of 8.67, ranking 16th in its industry. Analysts have a "Buy" rating for NMTC with an average target price of $2.23. The company's expected revenu

Tone
Positive 71/100
Event
Earnings
Published
18 Jun 2026 00:40
Source
TradingKey
TradingKey Direct company coverage

NeuroOne Medical Technologies Corp

This article from TradingKey provides an overview of NeuroOne Medical Technologies Corp (NMTC), including its stock performance and market capitalization. The main point of the article's content regarding revenue breakdown by business segment and region is that relevant data has

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 22:40
Source
TradingKey
TradingKey Direct company coverage

NeuroOne Medical Technologies Corp (NMTC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of NeuroOne Medical Technologies Corp's (NMTC) dividend and stock split history. It indicates that NMTC has not distributed any dividends over the past five years. However, it notes a stock split event scheduled for April 14, 2026, which is a 6-t

Tone
Neutral 50/100
Event
Capital return
Published
17 Jun 2026 22:40
Source
TradingKey
Market source Direct company coverage

NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index

NeuroOne Medical Technologies Corporation (NMTC) is expected to join the Russell Microcap® Index following the first semi-annual 2026 Russell indexes reconstitution. The company anticipates this inclusion will enhance its visibility among institutional investors and broaden its s

Tone
Positive 77/100
Event
Market update
Published
16 Jun 2026 12:09
Source
Market source
TradingView Direct company coverage

NeuroOne to sell up to $13.4M in common stock through updated ATM prospectus

NeuroOne (NMTC) has filed an updated prospectus to offer up to $13.4 million of common stock through its existing At-The-Market (ATM) program. The shares will be sold via JonesTrading under a Capital on Demand™ Sales Agreement, allowing the company to raise capital as needed. Thi

Tone
Neutral 50/100
Event
Macro sensitivity
Published
12 Jun 2026 20:39
Source
TradingView
Stock Titan Direct company coverage

NeuroOne (NASDAQ: NMTC) ups at‑the‑market capacity to $13.4M via JonesTrading

NeuroOne Medical Technologies Corporation has increased its at-the-market (ATM) sales agreement capacity with JonesTrading to $13.4 million. This supplement allows for additional common stock sales, leveraging an existing agreement from December 2022. The company had previously s

Tone
Neutral 50/100
Event
Market update
Published
12 Jun 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

NeuroOne Medical Technologies (NMTC) refreshes $13.4M at-the-market share offering

NeuroOne Medical Technologies (NMTC) has refreshed its at-the-market (ATM) stock offering, allowing it to sell up to $13.4 million in common shares through JonesTrading. This update, filed via a Prospectus Supplement on June 12, 2026, uses an existing Capital on Demand Sales Agre

Tone
Neutral 50/100
Event
Macro sensitivity
Published
12 Jun 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

NeuroOne Medical (NASDAQ: NMTC) restates revenue and warns on going concern

NeuroOne Medical Technologies Corporation has restated its Q2 2026 financial results due to duplicated revenue and cost entries, leading to a reduction in product revenue and gross profit. The company reported a significant net loss and reiterated substantial doubt about its abil

Tone
Negative 14/100
Event
Earnings
Published
12 Jun 2026 20:39
Source
Stock Titan
Market source Direct company coverage

NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time

NeuroOne Medical Technologies Corporation announced its participation in the Planet MicroCap Las Vegas 2026 Conference. Dave Rosa, President & CEO, will host one-on-one meetings with institutional investors and deliver a presentation on June 17, 2026, detailing commercialization

Tone
Positive 66/100
Event
Market update
Published
11 Jun 2026 12:40
Source
Market source